Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates

다국어 초록 (Multilingual Abstract)

Primary dysmenorrhea (PD) is a common, disregarded, underdiagnosed, and inadequately treated complaint of both young and adult females. It is characterized by painful cramps in the lower abdomen, which start shortly be-fore or at the onset of menses and which could last for 3 days. In particular, PD negatively impacts the quality of life (QOL) of young females and is the main reason behind their absenteeism from school or work. It is suggested that increased intrauterine secretion of prostaglandins F2α and E2 are responsible for the pelvic pain associated with this disorder. Its associated symptoms are physical and/or psychological. Its physical symptoms include headache, lethargy, sleep disturbances, tender breasts, various body pains, disturbed appetite, nausea, vomiting, constipation or diarrhea, and increased urination, whereas its psychological symptoms include mood disturbances, such as anxiety, depression, and irritability. While its diagnosis is based on patients’ history, symptoms, and physical exam-ination, its treatment aims to improve the QOL through the administration of nonsteroidal anti-inflammatory drugs, hormonal contraceptives, and/or the use of non-pharmacological aids (e.g., topical heat application and ex-ercise). Patients must be monitored to measure their response to treatment, assess their adherence, observe poten-tial side effects, and perform further investigations, if needed.

참고문헌 (Reference)

1 Iacovides S, "What we know about primary dysmenorrhea today : a critical review" 21 : 762-778, 2015

2 Curtis KM, "U.S. medical eligibility criteria for contraceptive use, 2016" 65 : 1-103, 2016

3 Abreu-Sanchez A, "Type of dysmenorrhea, menstrual characteristics and symptoms in nursing students in southern Spain" 8 : 302-, 2020

4 Gibson W, "Transcutaneous electrical nerve stimulation(TENS)for chronic pain : an overview of Cochrane Reviews" 4 : CD011890-, 2019

5 Johnson MI, "Transcutaneous electrical nerve stimulation for acute pain" 2015 : CD006142-, 2015

6 Johnson M, "Transcutaneous electrical nerve stimulation : mechanisms, clinical application and evidence" 1 : 7-11, 2007

7 Ryan SA, "The treatment of dysmenorrhea" 64 : 331-342, 2017

8 Maguire K, "The state of hormonal contraception today : established and emerging noncontraceptive health benefits" 205 (205): S4-S8, 2011

9 Ju H, "The prevalence and risk factors of dysmenorrhea" 36 : 104-113, 2014

10 Armour M, "The effectiveness of selfcare and lifestyle interventions in primary dysmenorrhea : a systematic review and meta-analysis" 19 : 22-, 2019

11 Lindh I, "The effect of combined oral contraceptives and age on dysmenorrhoea : an epidemiological study" 27 : 676-682, 2012

12 Igwea SE, "TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea : a systematic review" 24 : 86-91, 2016

13 Bourdel N, "Systematic review of endometriosis pain assessment : how to choose a scale?" 21 : 136-152, 2015

14 Proctor ML, "Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea" (4) : CD001896-, 2005

15 Armour M, "Self-care strategies and sources of knowledge on menstruation in 12, 526 young women with dysmenorrhea : a systematic review and meta-analysis" 14 : e0220103-, 2019

16 Chen CX, "Reasons women do not seek health care for dysmenorrhea" 27 : e301-e308, 2018

17 Lefebvre G, "Primary dysmenorrhea consensus guideline" 27 : 1117-1146, 2005

18 Chen L, "Primary dysmenorrhea and self-care strategies among Chinese college girls : a cross-sectional study" 9 : e026813-, 2019

19 Dawood MY, "Primary dysmenorrhea : advances in pathogenesis and management" 108 : 428-441, 2006

20 Rafique N, "Prevalence of menstrual problems and their association with psychological stress in young female students studying health sciences" 39 : 67-73, 2018

21 Abu Helwa HA, "Prevalence of dysmenorrhea and predictors of its pain intensity among Palestinian female university students" 18 : 18-, 2018

22 Unsal A, "Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students" 115 : 138-145, 2010

23 Subasinghe AK, "Prevalence and severity of dysmenorrhoea, and management options reported by young Australian women" 45 : 829-834, 2016

24 Matthewman G, "Physical activity for primary dysmenorrhea : a systematic review and meta-analysis of randomized controlled trials" 219 : 255.e1-255.e20, 2018

25 Chen CX, "Perceived ineffectiveness of pharmacological treatments for dysmenorrhea" 30 : 1334-1343, 2021

26 Hinz B, "Paracetamol and cyclooxygenase inhibition : is there a cause for concern?" 71 : 20-25, 2012

27 Berner E, "Pain reduction after total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy among women with dysmenorrhoea : a randomised controlled trial" 122 : 1102-1111, 2015

28 Wong CL, "Oral contraceptive pill for primary dysmenorrhoea" 2009 : CD002120-, 2009

29 Marjoribanks J, "Nonsteroidal antiinflammatory drugs for dysmenorrhoea" 2015 : CD001751-, 2015

30 Oladosu FA, "Nonsteroidal antiinflammatory drug resistance in dysmenorrhea : epidemiology, causes, and treatment" 218 : 390-400, 2018

31 Burnett M, "No. 345: primary dysmenorrhea consensus guideline" 39 : 585-595, 2017

32 Peng WW, "Neurobiological mechanisms of TENS-induced analgesia" 195 : 396-408, 2019

33 Duggan KC, "Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen" 285 : 34950-34959, 2010

34 Department of Reproductive Health, "Medical eligibility criteria for contraceptive use" World Health Organization

35 Parra-Fernandez ML, "Management of primary dysmenorrhea among university students in the south of Spain and family influence" 17 : 5570-, 2020

36 Kuphal GJ, "Integrative medicine" Elsevier Inc 569-577, 2018

37 Barcikowska Z, "Inflammatory markers in dysmenorrhea and therapeutic options" 17 : 1191-, 2020

38 Brandt A, "Hyperinsulinism hyperammonaemia(HI/HA)syndrome due to GLUD1 mutation : phenotypic variations ranging from late presentation to spontaneous resolution" 33 : 675-679, 2020

39 Jo J, "Heat therapy for primary dysmenorrhea : a systematic review and meta-analysis of its effects on pain relief and quality of life" 8 : 16252-, 2018

40 Wong CL, "Health-related quality of life among Chinese adolescent girls with dysmenorrhoea" 15 : 80-, 2018

41 Jones AV, "Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus" 157 : 2571-2581, 2016

42 Lazzaroni M, "Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations" 20 (20): 48-58, 2004

43 Latthe P, "Factors predisposing women to chronic pelvic pain : systematic review" 332 : 749-755, 2006

44 Daley AJ, "Exercise and primary dysmenorrhoea : a comprehensive and critical review of the literature" 38 : 659-670, 2008

45 Nie W, "Efficacy and safety of overthe-counter analgesics for primary dysmenorrhea: a network metaanalysis" 99 : e19881-, 2020

46 Bai HY, "Effect of transcutaneous electrical nerve stimulation therapy for the treatment of primary dysmenorrheal" 96 : e7959-, 2017

47 Wang SF, "Effect of transcutaneous electrical nerve stimulation on primary dysmenorrhea" 12 : 302-309, 2009

48 Proctor ML, "Dysmenorrhoea" 2007 : 0813-, 2007

49 Calis KA, "Dysmenorrhea: practice essentials, background, pathophysiology"

50 Harel Z, "Dysmenorrhea in adolescents and young adults : an update on pharmacological treatments and management strategies" 13 : 2157-2170, 2012

51 Bernardi M, "Dysmenorrhea and related disorders" 6 : 1645-, 2017

52 Morrow C, "Dysmenorrhea" 36 : 19-32, 2009

53 Kho KA, "Diagnosis and management of primary dysmenorrhea" 323 : 268-269, 2020

54 Proctor M, "Diagnosis and management of dysmenorrhoea" 332 : 1134-1138, 2006

55 Osayande AS, "Diagnosis and initial management of dysmenorrhea" 89 : 341-346, 2014

56 Chan WY, "Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects" 15 : 365-375, 1978

57 Katz JN, "Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities" 24 : 409-418, 2016

58 Mendiratta V, "Comprehensive gynecology" Elsevier Inc 815-828, 2017

59 Dawood MY, "Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea" 196 : 35.e1-35.e5, 2007

60 정재광 ; 변진석 ; 최재갑, "Basic Understanding of Transcutaneous Electrical Nerve Stimulation" 대한안면통증∙구강내과학회 41 (41): 145-154, 2016

61 Borgelt LM, "Applied therapeutics: the clinical use of drugs" Wolter Kluwer 1005-1027, 2018

62 Sharghi M, "An update and systematic review on the treatment of primary dysmenorrhea" 23 : 51-57, 2019

63 "ACOG committee opinion no. 760: dysmenorrhea and endometriosis in the adolescent" 132 : e249-e258, 2018

64 Agarwal AK, "A study of dysmenorrhea during menstruation in adolescent girls" 35 : 159-164, 2010